Try our Advanced Search for more refined results
July 22, 2008
AstraZeneca LP et al v. Mylan Pharmaceuticals Inc.
Case Number:
1:08-cv-00453
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 24, 2011
Mylan Crohn's Drug Doesn't Infringe AstraZeneca IP: Judge
A Delaware federal judge on Thursday ruled that Mylan Inc.'s generic version of Crohn's disease medication Entocort EC did not infringe a patent held by AstraZeneca Pharmaceuticals LP.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the parties now
Already a subscriber? Click here to login